Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Inventory (2022 - 2025)

Historic Inventory for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $35234.0.

  • bioAffinity Technologies' Inventory rose 3891.89% to $35234.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $35234.0, marking a year-over-year increase of 3891.89%. This contributed to the annual value of $27608.0 for FY2024, which is 4936.16% up from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Inventory is $35234.0, which was up 3891.89% from $43971.0 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Inventory peaked at $43971.0 during Q2 2025, and registered a low of $5540.0 during Q4 2022.
  • For the 4-year period, bioAffinity Technologies' Inventory averaged around $20868.9, with its median value being $18484.0 (2023).
  • In the last 5 years, bioAffinity Technologies' Inventory plummeted by 1630.35% in 2024 and then surged by 30879.1% in 2025.
  • bioAffinity Technologies' Inventory (Quarter) stood at $5540.0 in 2022, then surged by 233.65% to $18484.0 in 2023, then soared by 49.36% to $27608.0 in 2024, then rose by 27.62% to $35234.0 in 2025.
  • Its Inventory was $35234.0 in Q3 2025, compared to $43971.0 in Q2 2025 and $38782.0 in Q1 2025.